This EASL Deep Dive explores key updates from the EASL Clinical Practice Guidelines on hepatocellular carcinoma (HCC), with a practical focus on diagnosis and treatment selection. Experts will discuss evolving imaging and diagnostic criteria, patient selection for surgery and locoregional therapies, and how to adapt management according to response to systemic treatment. The session will also highlight the growing importance of multidisciplinary, individualised care across the HCC treatment pathway.
Learning objectives:
- Describe strategies to optimise the diagnosis of hepatocellular carcinoma (HCC).
- Identify optimal candidates for surgery and locoregional therapies.
- Explain how to manage patients according to their response to systemic treatment, including disease progression, complete response, partial response, and stable disease.
